BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15500376)

  • 1. Treatment strategies in controlling strongyloidiasis.
    Satoh M; Kokaze A
    Expert Opin Pharmacother; 2004 Nov; 5(11):2293-301. PubMed ID: 15500376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric strongyloidiasis and infection by the human T cell lymphotropic virus type 1 (HTLV-1).
    Lambertucci JR; Leão FC; Barbosa AJ
    Rev Soc Bras Med Trop; 2003; 36(4):541-2. PubMed ID: 12937738
    [No Abstract]   [Full Text] [Related]  

  • 3. [Disseminated strongyloidiasis].
    Nozais JP; Thellier M; Datry A; Danis M
    Presse Med; 2001 Apr; 30(16):813-8. PubMed ID: 11388155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: strongyloidiasis refractory to treatment with ivermectin.
    Ashraf M; Gue CL; Baddour LM
    Am J Med Sci; 1996 Apr; 311(4):178-9. PubMed ID: 8602647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection.
    Segarra-Newnham M
    Ann Pharmacother; 2007 Dec; 41(12):1992-2001. PubMed ID: 17940124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Strongyloides stercoralis: a puzzling parasite.
    Luvira V; Watthanakulpanich D; Pittisuttithum P
    Int Health; 2014 Dec; 6(4):273-81. PubMed ID: 25173343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An overview of Strongyloides stercoralis and its infections].
    Ardiç N
    Mikrobiyol Bul; 2009 Jan; 43(1):169-77. PubMed ID: 19334396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Moxidectin Versus Ivermectin Against Strongyloides stercoralis Infections: A Randomized, Controlled Noninferiority Trial.
    Barda B; Sayasone S; Phongluxa K; Xayavong S; Keoduangsy K; Odermatt P; Puchkov M; Huwyler J; Hattendorf J; Keiser J
    Clin Infect Dis; 2017 Jul; 65(2):276-281. PubMed ID: 28369530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Strongyloidiasis in nephrologic patients].
    Gravellone L; Battaglia C; Caligara F; D'Amato I; Gandini E; Lucatello A; Rizzo MA; Torpia R; Brigante G; Castiglioni A
    G Ital Nefrol; 2015; 32(2):. PubMed ID: 26005937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment failure in intestinal strongyloidiasis: an indicator of HTLV-I infection.
    Terashima A; Alvarez H; Tello R; Infante R; Freedman DO; Gotuzzo E
    Int J Infect Dis; 2002 Mar; 6(1):28-30. PubMed ID: 12044298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strongyloidiasis in a patient with acquired immunodeficiency syndrome.
    Ohnishi K; Kogure H; Kaneko S; Kato Y; Akao N
    J Infect Chemother; 2004 Jun; 10(3):178-80. PubMed ID: 15290458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infection due to Strongyloides stercoralis: epidemiological, clinical, diagnosis findings and outcome in 30 patients].
    Corti M; Villafañe MF; Trione N; Risso D; Abuín JC; Palmieri O
    Rev Chilena Infectol; 2011 Jun; 28(3):217-22. PubMed ID: 21879146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strongyloides stercoralis infection in an HIV positive patient--a case report from RIMS, Imphal, Manipur.
    Pukhrambam PD; Rebachandra H; Singh NB; Singh TN
    J Commun Dis; 2010 Sep; 42(3):231-4. PubMed ID: 22471190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human infection with Strongyloides stercoralis and other related Strongyloides species.
    Nutman TB
    Parasitology; 2017 Mar; 144(3):263-273. PubMed ID: 27181117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal serum IgE levels and eosinophil counts exhibited during Strongyloides stercoralis infection.
    Higashiarakawa M; Hirata T; Tanaka T; Parrott G; Kinjo T; Naka H; Hokama A; Fujita J
    Parasitol Int; 2017 Feb; 66(1):807-812. PubMed ID: 27744050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report.
    Pacanowski J; Santos MD; Roux A; LE Maignan C; Guillot J; Lavarde V; Cornet M
    Am J Trop Med Hyg; 2005 Jul; 73(1):122-4. PubMed ID: 16014846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe strongyloidiasis and systemic vasculitis: comorbidity, association or both? Case-based review.
    Miskovic R; Plavsic A; Bolpacic J; Raskovic S; Ranin J; Bogic M
    Rheumatol Int; 2018 Dec; 38(12):2315-2321. PubMed ID: 30353268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strongyloidiasis: A Neglected Tropical Disease.
    Krolewiecki A; Nutman TB
    Infect Dis Clin North Am; 2019 Mar; 33(1):135-151. PubMed ID: 30712758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The importance of Strongyloides stercoralis revisited].
    Pires ML; Dreyer G
    Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(4):175-82. PubMed ID: 8284589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
    Carvalho EM; Da Fonseca Porto A
    Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.